Dogwood State Bank (DSBX)
OTCMKTS · Delayed Price · Currency is USD
24.26
-0.18 (-0.76%)
Inactive · Last trade price on Jan 9, 2026
Dogwood State Bank Revenue
Dogwood State Bank had revenue of $25.54M in the quarter ending September 30, 2025, with 54.82% growth. This brings the company's revenue in the last twelve months to $100.17M, up 77.56% year-over-year. In the year 2024, Dogwood State Bank had annual revenue of $67.43M with 38.97% growth.
Revenue (ttm)
100.17M
Revenue Growth
+77.56%
P/S Ratio
5.62
Revenue / Employee
3.04M
Employees
33
Market Cap
563.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 67.43M | 18.91M | 38.97% |
| Dec 31, 2023 | 48.52M | 28.89M | 147.13% |
| Dec 31, 2020 | 19.63M | 8.42M | 75.04% |
| Dec 31, 2019 | 11.22M | 3.30M | 41.74% |
| Dec 31, 2016 | 7.91M | 734.00K | 10.22% |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionDogwood State Bank News
- 2 months ago - Dogwood State Bank Shareholders Approve Merger into TowneBank - PRNewsWire
- 6 months ago - KBRA Comments on TowneBank's Merger Agreement to Acquire Dogwood State Bank - Business Wire
- 6 months ago - Shareholder Alert: The Ademi Firm Investigates Whether Dogwood State Bank Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
- 10 months ago - Dogwood State Bank Reports Record Earnings in First Quarter of 2025 - PRNewsWire
- 11 months ago - Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward - GlobeNewsWire
- 1 year ago - Dogwood State Bank Reports Fourth Quarter and Full Year 2024 Results - PRNewsWire
- 1 year ago - Dogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025 - GlobeNewsWire
- 1 year ago - Dogwood Therapeutics Announces Third Quarter 2024 Financial Results - GlobeNewsWire